News Briefs Alpha-9 Oncology nabs $175m Series C Lightspeed Venture Partners and Ascenta Capital led the round. Iris Dorbian - 23 October 2024 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
